$DMRC
Digimarc CORP Stock $dmrc

$dmrc Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924006115 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$9.938M	$9.284M	$34.85M
YoY Change	26.71%	28.62%	15.41%
Cost Of Revenue	$3.726M	$3.720M	$14.69M
YoY Change	3.53%	6.26%	-1.26%
Gross Profit	$6.212M	$5.564M	$20.17M
YoY Change	46.37%	49.69%	31.6%
Gross Profit Margin	62.51%	59.93%	57.86%
Selling, General & Admin	$10.06M	$10.30M	$40.48M
YoY Change	-7.95%	3.66%	-16.82%
% of Gross Profit	161.88%	185.08%	200.74%
Research & Development	$6.741M	$6.282M	$26.58M
YoY Change	-13.86%	-7.06%	0.33%
% of Gross Profit	108.52%	112.9%	131.8%
Depreciation & Amortization	$1.876M	$1.845M	$7.611M
YoY Change	-4.29%	4.89%	-0.04%
% of Gross Profit	30.2%	33.16%	37.74%
Operating Expenses	$17.07M	$16.58M	$68.37M
YoY Change	-10.22%	-0.68%	-11.36%
Operating Profit	-$10.86M	-$11.02M	-$48.21M
YoY Change	-26.48%	-15.1%	-22.01%
Interest Expense	$403.0K	$243.0K	$1.584M
YoY Change	-17.76%
% of Operating Profit
Other Income/Expense, Net	$528.0K	$339.0K	$2.452M
YoY Change	-29.13%	-62.08%	16.32%
Pretax Income	-$10.33M	-$10.43M	-$45.76M
YoY Change	-26.34%	-16.01%	-23.36%
Income Tax	$9.000K	$139.0K	$204.0K
% Of Pretax Income
Net Earnings	-$10.34M	-$10.57M	-$45.96M
YoY Change	-26.37%	-15.06%	-23.14%
Net Earnings / Revenue	-104.02%	-113.88%	-131.87%
Basic Earnings Per Share	-$0.50		-$2.26
Diluted Earnings Per Share	-$0.50	-$0.51	-$2.26
COMMON SHARES
Basic Shares Outstanding	20.44M	20.36M	20.32M
Diluted Shares Outstanding	20.73M		20.32M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$48.93M	$27.18M	$27.18M
YoY Change	13.71%	-19.1%	-48.27%
Cash & Equivalents	$36.41M	$21.46M	$21.46M
Short-Term Investments	$12.51M	$5.726M	$5.726M
Other Short-Term Assets	$3.802M	$4.085M	$4.085M
YoY Change	-14.7%	-33.81%	-33.81%
Inventory
Prepaid Expenses
Receivables	$5.215M	$5.813M	$5.813M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$57.94M	$37.08M	$37.08M
YoY Change	10.77%	-42.19%	-42.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.445M	$1.570M	$5.587M
YoY Change	-28.61%	-34.31%	-21.42%
Goodwill	$8.576M	$8.641M
YoY Change	1.67%	5.01%
Intangibles	$26.72M	$28.46M
YoY Change	-17.52%	-14.21%
Long-Term Investments
YoY Change
Other Assets	$1.106M	$786.0K	$786.0K
YoY Change	-15.51%	-30.26%	-30.26%
Total Long-Term Assets	$41.78M	$43.47M	$43.47M
YoY Change	-14.25%	-12.42%	-12.42%
TOTAL ASSETS
Total Short-Term Assets	$57.94M	$37.08M	$37.08M
Total Long-Term Assets	$41.78M	$43.47M	$43.47M
Total Assets	$99.72M	$80.55M	$80.55M
YoY Change	-1.29%	-29.2%	-29.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.400M	$6.090M	$6.090M
YoY Change	-32.79%	20.59%	20.59%
Accrued Expenses	$700.0K	$582.0K	$582.0K
YoY Change	-21.44%	-38.02%	-38.02%
Deferred Revenue	$5.256M	$5.853M
YoY Change	61.03%	41.21%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.356M	$12.53M	$12.53M
YoY Change	12.41%	23.59%	23.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$80.00K	$106.0K	$6.100M
YoY Change	-44.06%	39.47%	0.78%
Total Long-Term Liabilities	$80.00K	$106.0K	$6.100M
YoY Change	-44.06%	39.47%	0.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.356M	$12.53M	$12.53M
Total Long-Term Liabilities	$80.00K	$106.0K	$6.100M
Total Liabilities	$15.25M	$18.63M	$18.63M
YoY Change	6.13%	15.06%	15.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$322.1M	-$311.8M
YoY Change	15.1%	17.29%
Common Stock	$21.00K	$20.00K
YoY Change	5.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$84.47M	$61.93M	$61.93M
YoY Change
Total Liabilities & Shareholders Equity	$99.72M	$80.55M	$80.55M
YoY Change	-1.29%	-29.2%	-29.2%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$10.34M	-$10.57M	-$45.96M
YoY Change	-26.37%	-15.06%	-23.14%
Depreciation, Depletion And Amortization	$1.876M	$1.845M	$7.611M
YoY Change	-4.29%	4.89%	-0.04%
Cash From Operating Activities	-$8.422M	-$5.316M	-$22.00M
YoY Change	-3.68%	-29.31%	-50.47%
INVESTING ACTIVITIES
Capital Expenditures	$106.0K	$237.0K	$314.0K
YoY Change	107.84%	-15.36%	-66.38%
Acquisitions
YoY Change
Other Investing Activities	-$6.819M	-$4.731M	$13.30M
YoY Change	-182.43%	63.76%	154.61%
Cash From Investing Activities	-$7.031M	-$4.968M	$12.56M
YoY Change	-186.71%	56.77%	234.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.724M
YoY Change			15.62%
Debt Paid & Issued, Net	$15.00K		$36.00K
YoY Change	-42.31%		2.86%
Cash From Financing Activities	$30.42M	-691.0K	-$2.760M
YoY Change	-4560.7%	-117.85%	-104.56%
NET CHANGE
Cash From Operating Activities	-$8.422M	-5.316M	-$22.00M
Cash From Investing Activities	-$7.031M	-4.968M	$12.56M
Cash From Financing Activities	$30.42M	-691.0K	-$2.760M
Net Change In Cash	$14.96M	-10.98M	-$12.14M
YoY Change	-1253.28%	60.97%	-161.3%
FREE CASH FLOW
Cash From Operating Activities	-$8.422M	-$5.316M	-$22.00M
Capital Expenditures	$106.0K	$237.0K	$314.0K
Free Cash Flow	-$8.528M	-$5.553M	-$22.31M
YoY Change	-3.04%	-28.81%	-50.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20379000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20379000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20260000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20260000
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	dmrc	Subscription Revenue Term Minimum SubscriptionRevenueTermMinimum	P1Y
CY2023	dmrc	Subscription Revenue Term Maximum SubscriptionRevenueTermMaximum	P3Y
CY2023	dmrc	Period Of Revenue From Services PeriodOfRevenueFromServices	P1M
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	dmrc	State Tax Credit Carry Forward Expiration Period Minimum StateTaxCreditCarryForwardExpirationPeriodMinimum	P5Y
CY2023	dmrc	State Tax Credit Carry Forward Expiration Period Maximum StateTaxCreditCarryForwardExpirationPeriodMaximum	P20Y
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-34108
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OR
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2828185
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	8500 SW Creekside Place
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beaverton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	OR
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	97008
CY2023	dei	City Area Code CityAreaCode	503
CY2023	dei	Local Phone Number LocalPhoneNumber	469-4800
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.001 Par Value Per Share
CY2023	dei	Trading Symbol TradingSymbol	DMRC
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	475000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20443596
CY2023	dei	Auditor Name AuditorName	KPMG, LLP
CY2023	dei	Auditor Location AuditorLocation	Portland, Oregon
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21456000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33598000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5726000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	18944000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5813000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5427000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4085000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6172000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	37080000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	64141000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1570000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2390000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28458000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33170000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	8641000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8229000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4017000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4720000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	786000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1127000	usd
CY2023Q4	us-gaap	Assets Assets	80552000	usd
CY2022Q4	us-gaap	Assets Assets	113777000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6672000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5989000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5853000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4145000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12525000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10134000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5994000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5977000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	106000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	76000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	18625000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	16187000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	50000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	50000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	376189000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	367692000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-311768000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-265809000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2564000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4363000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	61927000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97590000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	80552000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	113777000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34851000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30197000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14686000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14874000	usd
CY2023	us-gaap	Gross Profit GrossProfit	20165000	usd
CY2022	us-gaap	Gross Profit GrossProfit	15323000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22409000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29718000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26577000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26490000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18071000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18945000	usd
CY2023	dmrc	Amortization Expense On Acquired Intangible Assets AmortizationExpenseOnAcquiredIntangibleAssets	1065000	usd
CY2022	dmrc	Amortization Expense On Acquired Intangible Assets AmortizationExpenseOnAcquiredIntangibleAssets	1064000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	250000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	915000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	68372000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	77132000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-48207000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-61809000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2452000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2108000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45755000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59701000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	89000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	335000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	204000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	97000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45959000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59798000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.26
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.12
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.26
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.12
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20322000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19140000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20322000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19140000
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	138000	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-144000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1661000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4219000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1799000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4363000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45959000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59798000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44160000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-64161000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97590000	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2724000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11221000	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	138000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1661000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45959000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	61927000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55380000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	95709000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1601000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2356000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11417000	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-144000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4219000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59798000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97590000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45959000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59798000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1121000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1372000	usd
CY2023	dmrc	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	5524000	usd
CY2022	dmrc	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	5503000	usd
CY2023	dmrc	Amortization And Writeoff Of Other Intangible Assets AmortizationAndWriteoffOfOtherIntangibleAssets	966000	usd
CY2022	dmrc	Amortization And Writeoff Of Other Intangible Assets AmortizationAndWriteoffOfOtherIntangibleAssets	739000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	517000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	965000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	11158000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	11289000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	250000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	915000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2232000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2200000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1933000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-299000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	520000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	660000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3856000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1627000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-371000	usd
CY2023	dmrc	Increase Decrease In Lease Liability And Other Long Term Liabilities IncreaseDecreaseInLeaseLiabilityAndOtherLongTermLiabilities	-43000	usd
CY2022	dmrc	Increase Decrease In Lease Liability And Other Long Term Liabilities IncreaseDecreaseInLeaseLiabilityAndOtherLongTermLiabilities	-1034000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21995000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44408000	usd
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-0	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3512000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	314000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	934000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	426000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	533000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	27664000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	21425000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14363000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	12689000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12561000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3757000	usd
CY2023	dmrc	Proceeds From Payments For Issuance Of Common Stock ProceedsFromPaymentsForIssuanceOfCommonStock	0	usd
CY2022	dmrc	Proceeds From Payments For Issuance Of Common Stock ProceedsFromPaymentsForIssuanceOfCommonStock	62890000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2724000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2356000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	36000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	35000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2760000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60499000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-39000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12142000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19809000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33598000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13789000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21456000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33598000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-233000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-61000	usd
CY2023	dmrc	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	6000	usd
CY2022	dmrc	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	-9000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	63000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	128000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	32393000	usd
CY2023	dmrc	Warrants Issued For Acquisition WarrantsIssuedForAcquisition	0	usd
CY2022	dmrc	Warrants Issued For Acquisition WarrantsIssuedForAcquisition	1601000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	31000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5176000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 13pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. The Company’s accounting policy for revenue recognition requires a higher degrees of judgment than others in their application. Management bases its estimates on historical experience and on other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <em style="font: inherit;">not</em> readily apparent from other sources. Actual results <em style="font: inherit;"> may </em>differ from these estimates under different assumptions or conditions.</p>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	17362000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	31452000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 13pt;"><b><i>Concentrations of Business and Credit Risk</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">A significant portion of the Company’s business depends on a limited number of large contracts. The loss of any large contract <em style="font: inherit;"> may </em>result in loss of revenue and margin on a prospective basis. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"><span style="background-color:#ffffff;">The Company places its cash and cash equivalents with major banks and financial institutions and at times deposits <em style="font: inherit;"> may </em>exceed insured limits. Other than cash used for operating needs, which <em style="font: inherit;"> may </em>include short-term marketable securities with the Company’s principal banks, the Company’s investment policy limits its credit exposure to any <em style="font: inherit;">one</em> financial institution or type of financial instrument by limiting the maximum of 5% of its cash equivalents and marketable securities or $1,000, whichever is greater, to be invested in any <em style="font: inherit;">one</em> issuer except for the U.S. government, U.S. federal agencies and U.S. backed securities, which have <em style="font: inherit;">no</em> limits, at the time of purchase. The Company’s investment policy also limits its credit exposure by limiting the maximum of 40% of its cash equivalents and marketable securities, or $15,000, whichever is greater, to be invested in any <em style="font: inherit;">one</em> industry category, (e.g., financial, energy, etc.), at the time of purchase. As a result, the Company’s credit risk associated with cash and cash equivalents and marketable securities is believed to be minimal.</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">The Company manages credit risk on accounts receivable by evaluating a customer’s credit worthiness before extending any significant amount of credit. There is a significant concentration of accounts receivable at various times from our <em style="font: inherit;">two</em> largest customers. Both customers have significant financial means and a history of paying their invoices timely. The Company does <em style="font: inherit;">not</em> have a history of significant bad debt write-offs. As a result, the Company’s credit risk associated with accounts receivable is believed to be low.</p>
CY2023Q4	dmrc	Percentage Of Concentration Risk Credit Risk Financial Instruments Under Option One PercentageOfConcentrationRiskCreditRiskFinancialInstrumentsUnderOptionOne	0.05	pure
CY2023	dmrc	Concentration Risk Credit Risk Financial Instruments Under Option Two ConcentrationRiskCreditRiskFinancialInstrumentsUnderOptionTwo	1000000	usd
CY2023	dmrc	Percentage Of Credit Exposure Limits Based On Cash And Cash Equivalents And Marketable Securities PercentageOfCreditExposureLimitsBasedOnCashAndCashEquivalentsAndMarketableSecurities	0.40	pure
CY2023	dmrc	Credit Exposure Limits Of Cash And Cash Equivalents And Marketable Securities Under Option Two CreditExposureLimitsOfCashAndCashEquivalentsAndMarketableSecuritiesUnderOptionTwo	15000000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	23088000	usd
CY2023Q4	dmrc	Cash Equivalents And Marketable Securities Maturity Less Than One Year Fair Value CashEquivalentsAndMarketableSecuritiesMaturityLessThanOneYearFairValue	23088000	usd
CY2023Q4	dmrc	Cash Equivalents And Marketable Securities Maturity Year One Through Five Year Fair Value CashEquivalentsAndMarketableSecuritiesMaturityYearOneThroughFiveYearFairValue	0	usd
CY2023Q4	dmrc	Cash Equivalents And Marketable Securities Maturity Year Five Through Ten Year Fair Value CashEquivalentsAndMarketableSecuritiesMaturityYearFiveThroughTenYearFairValue	0	usd
CY2023Q4	dmrc	Cash Equivalents And Marketable Securities Maturity More Than Ten Year Fair Value CashEquivalentsAndMarketableSecuritiesMaturityMoreThanTenYearFairValue	0	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34851000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30197000	usd
CY2023Q4	dmrc	Contract Acquisition Costs Current ContractAcquisitionCostsCurrent	113000	usd
CY2022Q4	dmrc	Contract Acquisition Costs Current ContractAcquisitionCostsCurrent	197000	usd
CY2023Q4	dmrc	Contract Acquisition Costs Noncurrent ContractAcquisitionCostsNoncurrent	9000	usd
CY2022Q4	dmrc	Contract Acquisition Costs Noncurrent ContractAcquisitionCostsNoncurrent	104000	usd
CY2023Q4	dmrc	Contract Acquisition Costs Total ContractAcquisitionCostsTotal	122000	usd
CY2022Q4	dmrc	Contract Acquisition Costs Total ContractAcquisitionCostsTotal	301000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5853000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4145000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5860000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4160000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4085000	usd
CY2023Q4	dmrc	Contract With Customer Liability Transaction Price From Contractual Obligations ContractWithCustomerLiabilityTransactionPriceFromContractualObligations	31798000	usd
CY2022Q4	dmrc	Contract With Customer Liability Transaction Price From Contractual Obligations ContractWithCustomerLiabilityTransactionPriceFromContractualObligations	29600000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34851000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30197000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11158000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11289000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	63000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	128000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	11221000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	11417000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	15370000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	16051000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	50000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.54
CY2022Q1	dmrc	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	22.23
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	22.15
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	dmrc	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	51000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.14
CY2022Q4	dmrc	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	21.72
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	dmrc	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	50000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	39.54
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	22.23
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.15
CY2023Q4	dmrc	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5947000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5541000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	9000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	37000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	134000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.15
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1000
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y10M6D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	22.15
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1000
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P6Y10M6D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	22.15
CY2022Q1	us-gaap	Share Price SharePrice	40.84
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45959000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59798000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20322000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19140000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.26
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.12
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45959000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59798000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20322000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19140000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.26
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.12
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	134000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	114000	usd
CY2023Q4	dmrc	Trade Receivable Net TradeReceivableNet	5822000	usd
CY2022Q4	dmrc	Trade Receivable Net TradeReceivableNet	5464000	usd
CY2023Q4	dmrc	Unpaid Deferred Revenues Included In Accounts Receivable UnpaidDeferredRevenuesIncludedInAccountsReceivable	2073000	usd
CY2022Q4	dmrc	Unpaid Deferred Revenues Included In Accounts Receivable UnpaidDeferredRevenuesIncludedInAccountsReceivable	2183000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1435000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1613000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5497000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5747000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2472000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4785000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1861000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1861000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11265000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14006000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9695000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11616000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1570000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2390000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1114000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7970000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-855000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8229000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	412000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	8641000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43230000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14772000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28458000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6097000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6078000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6194000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6175000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6142000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1542000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1531000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4017000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4720000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5994000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5977000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	250000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	915000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1556000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1905000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1151000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1572000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1186000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1317000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1356000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1397000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1296000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2455000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9007000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2431000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6576000	usd
CY2008Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000
CY2008Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2008Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2008Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9000	usd
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.75	pure
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1217000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1365000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1680000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	744000	usd
CY2023	dmrc	Refundable Tax Credit Nonoperating RefundableTaxCreditNonoperating	684000	usd
CY2022	dmrc	Refundable Tax Credit Nonoperating RefundableTaxCreditNonoperating	1260000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	96000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	86000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2452000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2108000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	141000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	60000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	20000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	37000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	34000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	187000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	114000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	17000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-17000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	204000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	97000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9609000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12537000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11716000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	13463000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.22	pure
CY2023	dmrc	Effective Income Tax Rate Reconciliation Nol Surrendered For Tax Credit Refundable Amount EffectiveIncomeTaxRateReconciliationNolSurrenderedForTaxCreditRefundableAmount	-1607000	usd
CY2023	dmrc	Effective Income Tax Rate Reconciliation Nol Surrendered For Tax Credit Refundable Amount Percent EffectiveIncomeTaxRateReconciliationNolSurrenderedForTaxCreditRefundableAmountPercent	0.04	pure
CY2022	dmrc	Effective Income Tax Rate Reconciliation Nol Surrendered For Tax Credit Refundable Amount EffectiveIncomeTaxRateReconciliationNolSurrenderedForTaxCreditRefundableAmount	-2164000	usd
CY2022	dmrc	Effective Income Tax Rate Reconciliation Nol Surrendered For Tax Credit Refundable Amount Percent EffectiveIncomeTaxRateReconciliationNolSurrenderedForTaxCreditRefundableAmountPercent	0.04	pure
CY2023	dmrc	Effective Income Tax Rate Reconciliation Deductions And Credits Foreign Research EffectiveIncomeTaxRateReconciliationDeductionsAndCreditsForeignResearch	803000	usd
CY2023	dmrc	Effective Income Tax Rate Reconciliation Deductions And Credits Foreign Research Percent EffectiveIncomeTaxRateReconciliationDeductionsAndCreditsForeignResearchPercent	-0.02	pure
CY2022	dmrc	Effective Income Tax Rate Reconciliation Deductions And Credits Foreign Research EffectiveIncomeTaxRateReconciliationDeductionsAndCreditsForeignResearch	1329000	usd
CY2022	dmrc	Effective Income Tax Rate Reconciliation Deductions And Credits Foreign Research Percent EffectiveIncomeTaxRateReconciliationDeductionsAndCreditsForeignResearchPercent	-0.02	pure
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1412000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.03	pure
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1037000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.02	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-468000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-491000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01	pure
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-827000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.03	pure
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-136000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	204000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	97000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	dmrc	Deferred Tax Assets Operating Loss Carryforward Federal And State DeferredTaxAssetsOperatingLossCarryforwardFederalAndState	77201000	usd
CY2022Q4	dmrc	Deferred Tax Assets Operating Loss Carryforward Federal And State DeferredTaxAssetsOperatingLossCarryforwardFederalAndState	74270000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	12406000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	10869000	usd
CY2023Q4	dmrc	Deferred Tax Assets Research And Experimental Costs DeferredTaxAssetsResearchAndExperimentalCosts	9458000	usd
CY2022Q4	dmrc	Deferred Tax Assets Research And Experimental Costs DeferredTaxAssetsResearchAndExperimentalCosts	4837000	usd
CY2023Q4	dmrc	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1468000	usd
CY2022Q4	dmrc	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1508000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1474000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	482000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	185000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	87000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	36000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	610000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	69000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	59000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	43000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	102861000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	92201000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	95256000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7605000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9201000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Patent Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts	1096000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Patent Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts	1464000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	897000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1049000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	9000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	28000	usd
CY2023Q4	dmrc	Deferred Tax Assets Goodwilland Intangible Assets Intangible Assets DeferredTaxAssetsGoodwillandIntangibleAssetsIntangibleAssets	-5603000	usd
CY2022Q4	dmrc	Deferred Tax Assets Goodwilland Intangible Assets Intangible Assets DeferredTaxAssetsGoodwillandIntangibleAssetsIntangibleAssets	-6644000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7605000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9185000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	16000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	95256000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83000000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12256000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	247472000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	178519000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	68925000	usd
CY2023	dmrc	Federal Net Operating Loss Carryforwards Expiration Period Minimum FederalNetOperatingLossCarryforwardsExpirationPeriodMinimum	P5Y
CY2023	dmrc	Federal Tax Credit Carryforward Expiration Period Maximum FederalTaxCreditCarryforwardExpirationPeriodMaximum	P20Y
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1046000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	918000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	94000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	98000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	30000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	77000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	-0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1063000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1046000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd

Files In Submission

Name	View Source	Status
0001437749-24-006115-index-headers.html	Edgar Link	pending
0001437749-24-006115-index.html	Edgar Link	pending
0001437749-24-006115.txt	Edgar Link	pending
0001437749-24-006115-xbrl.zip	Edgar Link	pending
dmrc-20231231.xsd	Edgar Link	pending
dmrc20231231d_10k.htm	Edgar Link	pending
dmrcsigpage.jpg	Edgar Link	pending
ex_606392.htm	Edgar Link	pending
ex_606393.htm	Edgar Link	pending
ex_606394.htm	Edgar Link	pending
ex_606395.htm	Edgar Link	pending
ex_606396.htm	Edgar Link	pending
ex_606397.htm	Edgar Link	pending
ex_627493.htm	Edgar Link	pending
ex_627963.htm	Edgar Link	pending
ex_627964.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img01logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
dmrc-20231231_def.xml	Edgar Link	unprocessable
dmrc-20231231_lab.xml	Edgar Link	unprocessable
dmrc-20231231_pre.xml	Edgar Link	unprocessable
dmrc20231231d_10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dmrc-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DMRC
Digimarc CORP Stock $dmrc

2024 Q1 Form 10-K Financial Statement

#000143774924006115 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DMRC Digimarc CORP Stock $dmrc

2024 Q1 Form 10-K Financial Statement

#000143774924006115 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DMRC
Digimarc CORP Stock $dmrc